Director Frederick J. Fritz filed a Form 4 with the SEC on November 10, 2026, disclosing the acquisition of 13.166 shares of Imunon, Inc. common stock on November 6, 2026, granted in lieu of cash for a portion of board fees.

Key Highlights

  • Reporting person: Frederick J. Fritz, identified as a Director of Imunon, Inc. (NASDAQ:IMNN)
  • Transaction date: November 6, 2026
  • Shares acquired: 13.166 shares of common stock, transaction code "A" (acquired)
  • Price per share: $0.845
  • Nature of grant: Stock granted in lieu of cash for a portion of board fees, per the filing's footnote
  • Beneficial ownership following transaction: 28,242 shares, held directly

Imunon Director Fritz Acquires Shares as Board Fee Compensation

According to the Form 4 filed on November 10, 2026, Frederick J. Fritz, a director of Imunon, Inc. (NASDAQ:IMNN), acquired 13.166 shares of the company's common stock on November 6, 2026, at a price of $0.845 per share. The filing notes that this stock was "granted in lieu of cash for portion of board fees," indicating a non-cash compensation arrangement rather than an open-market purchase.

The transaction is recorded under transaction code "A," denoting an acquisition, in Table I of the Form 4 covering non-derivative securities. Following this transaction, the filing reports that Fritz directly beneficially owns 28,242 shares of Imunon common stock. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Jeffrey W. Church as attorney in fact for Frederick Fritz and was filed with the SEC on November 10, 2026. The date of earliest transaction listed on the filing is November 6, 2026. No amendment date was indicated, suggesting this is an original filing.

What Was Disclosed

Imunon director Frederick J. Fritz disclosed the acquisition of 13.166 shares of common stock at $0.845 per share on November 6, 2026, as stock granted in lieu of cash board fees, bringing his direct beneficial ownership to 28,242 shares.